Skip to Content

Research by Bruce Branchaud Leads to New Drug

A new anti-inflammatory drug moving into phase two clinical trials to treat two serious diseases was built on a scientific collaboration with UO chemist, Bruce Branchaud.

Read more in AroundtheO and the Daily Emerald:

Drug entering clinical trials has fingerprint of UO chemist

New drug developed by UO chemist could help kidney disease sufferers

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to toolbar